CLOs on the Move

Stilla Technologies

www.stillatechnologies.com

 
Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

First Continental International (NJ)

First Continental International (NJ) is a Rochelle Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ultracision

Ultracision, Inc. is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Mercy Mc Mahon Terrace

Mercy Mc Mahon Terrace is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pennsylvania Health Care Cost Containment Council

The Pennsylvania Health Care Cost Containment Council (PHC4) is an independent state agency responsible for addressing the problem of escalating health costs, ensuring the quality of health care, and increasing access for all citizens regardless of ability to pay.

Brighton Health Plan Solutions

Brighton Health Group is BHPS`s parent company whose approach it is to create an ecosystem in which everyone`s success is contingent upon better health for patients. BHG`s businesses collaborate with physicians, payors and plan sponsors to align the economics with better results, enabling consumers to make better decisions. Combining expertise in healthcare economics with operations drives transformation across the healthcare value chain. BHG aligns financial incentives with quality outcomes and clinical accountability. This formula is building a sustainable business model based on shared rewards between the providers, payors, and health plan sponsors.